The efficacy of pregabalin for acute pain control in herpetic neuralgia patients
@article{Wang2017TheEO, title={The efficacy of pregabalin for acute pain control in herpetic neuralgia patients}, author={Suo-liang Wang and Hua Wang and Hui-yong Nie and Gang Bu and Xi Shen and Hui Wang}, journal={Medicine}, year={2017}, volume={96} }
Objective: This meta-analysis aimed to illustrate the efficacy and safety of preganalin for pain management in patients with postherpetic neuralgia (PHN). Methods: In July 2017, a systematic computer-based search was conducted in PubMed, EMBASE, Web of Science, Cochrane Database of Systematic Reviews, and Google database. Data on patients with PHN that compared pregabalin versus placebo were retrieved. The endpoints were the visual analog scale (VAS) at 8 weeks, the percentage of 30% and 50…
13 Citations
COMPARISON OF PREGABALIN AND NORTRIPTYLINE ON EFFICACY AND SAFETY IN POSTHERPETIC NEURALGIA
- Medicine, PsychologyAsian Journal of Pharmaceutical and Clinical Research
- 2021
Both pregabalin and nortriptyline were effective in patients of PHN, but pre gabalin was found to be better than nortriptYline at 8 weeks, and both drugs were well tolerated, though preg abalin had lesser number of ADRs.
Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials
- Medicine, PsychologyBMJ Open
- 2019
Pregabalin has beneficial effects on some symptoms of neuropathic pain, however, its use significantly increases the risk of a number of adverse events and discontinuation due to adverse events.
Topical Lidocaine Medicated Plaster 5% and Pregabalin for the Treatment of Post-Herpetic Neuralgia: A Systematic Review and Meta-Analysis
- MedicineJournal of Pharmaceutical Research International
- 2022
Five % lidocaine medicated plaster was effective for the treatment of post-herpetic neuralgia and was more beneficial than placebo and pregabalin.
Oral pharmacotherapeutics for the management of peripheral neuropathic pain conditions – a review of clinical trials
- MedicineExpert opinion on pharmacotherapy
- 2020
This narrative review presents the results of different prospective, randomized controlled trials, systematic reviews and meta-analyses assessing the effects of different oral medications in the management of various peripheral neuropathic pain conditions and concludes that none of them were significantly superior.
Ultrasound-guided Pulsed Radiofrequency in the Management of Thoracic Postherpetic Neuralgia: A Randomized, Double-blinded, Controlled Trial
- MedicineThe Clinical journal of pain
- 2018
Ultrasound-guided PRF for ICNs in combination with pharmacotherapy seems to be a safe and effective treatment modality for postherpetic neuralgia.
Preemptive pregabalin for postoperative analgesia during minimally invasive hysterectomy: a systematic review and meta-analysis of randomized controlled trials
- MedicineObstetrics & gynecology science
- 2022
Compared with placebo, preemptive pregabalin was largely safe, and was correlated with superior analgesic effects in terms of lower postoperative pain scores and higher opioid-sparing effects.
Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: a Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial.
- Medicine, PsychologyClinical therapeutics
- 2020
[S2k guideline for the diagnosis and therapy of zoster and post-zoster neuralgia].
- MedicineGMS infectious diseases
- 2020
This guideline provides an overview of clinical and molecular diagnostics as well as antigen detection, antibody culture and viral culture and the antiviral therapy of zoster and postzoster neuralgia.
Topical gabapentin gel alleviates allodynia and hyperalgesia in the chronic sciatic nerve constriction injury neuropathic pain model
- Medicine, BiologyEuropean journal of pain
- 2017
A topical gabapentin dermal application was examined in the chronic constriction injury (CCI) model of neuropathic pain to curtail side‐effects.
S2k‐Leitlinie zur Diagnostik und Therapie des Zoster und der Postzosterneuralgie
- MedicineJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
- 2020
Die Leitlinie wurde im formellen Konsensusverfahren (S2k) von Dermatologen, Virologen/Infektiologicen, Ophthalmologisten, HNO‐Ärzten, Neurologen, Pädiatern and Anästhesisten/Schmerzmedizinern erstellt.
References
SHOWING 1-10 OF 32 REFERENCES
Efficacy of pregabalin in the treatment of postherpetic neuralgia : a meta-analysis of randomized controlled trials
- Medicine, Psychology
- 2016
Pregabalin is effective in reducing the mean pain score and sleep interference score, increasing the percentage of 30% and 50% pain responders in comparison with placebo, and the effect of different dosing regimens on the treatment outcome.
Pregabalin for the treatment of postherpetic neuralgia
- Medicine, PsychologyNeurology
- 2003
Treatment of postherpetic neuralgia with pregabalin is safe, efficacious in relieving pain and sleep interference, and associated with greater global improvement than treatment with placebo.
The Effectiveness and Safety of Topical Capsaicin in Postherpetic Neuralgia: A Systematic Review and Meta-analysis
- Medicine, PsychologyFront. Pharmacol.
- 2017
Topical capsaicin is a promising treatment option for specific patient groups or certain neuropathic pain conditions such as postherpetic neuralgia, and the significance of safety data cannot be quantified due to a lack of p-values in the original studies.
Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial
- Medicine, PsychologyPain
- 2004
Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis
- MedicineThe Korean journal of pain
- 2017
Applying nerve blocks during the acute phase of the herpes zoster shortens the duration of zoster-related pain, and somatic blocks (including paravertebral and repeated/continuous epidural blocks) are recommended to prevent PHN.
The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
- Medicine, PsychologyPain and Therapy
- 2016
Pregabalin is an effective treatment for PHN and even for pNeP extensively, but at increased cost, and leads to improved outcomes including lower pain scores and more days with no or mild pain.
Systematic Review and Meta-analysis of the Efficacy of Oral Medications Compared with Placebo Treatment in the Management of Postherpetic Neuralgia.
- Medicine, PsychologyJournal of oral & facial pain and headache
- 2018
This review provided favorable but low-quality evidence to support the use of anticonvulsants for PHN, although statistically significant effects were observed for posttreatment pain and the percent of responders, the number of studies in each subgroup analysis for anticonVulsants was small and the included studies had high or unclear risk of bias.
Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trial
- Medicine, PsychologyCurrent medical research and opinion
- 2006
Pregabalin, dosed BID, reduced neuropathic pain associated with PHN and was well tolerated; it also reduced the extent to which pain interfered with sleep.
Post-herpetic Neuralgia: a Review
- Medicine, PsychologyCurrent Pain and Headache Reports
- 2016
Post-herpetic neuralgia (PHN) is a chronic neuropathic pain condition that persists 3 months or more following an outbreak of shingles. Shingles, also known as acute herpes zoster, is associated with…
Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center
- Medicine, PsychologyThe Journal of dermatology
- 2017
Approval of pregabalin appeared to result in a treatment paradigm toward use of an approved therapy with demonstrated efficacy in postherpetic neuralgia, with significant reductions in prescription of non‐steroidal anti‐inflammatory drugs, tricyclic antidepressants and neurotrophin relative to before approval.